Close Menu

NEW YORK – The US Food and Drug Administration issued new guidance on Tuesday for molecular diagnostic tests for influenza and respiratory syncytial virus, allowing developers to modify already-cleared tests in certain ways to make flu and RSV tests more widely available while also preserving reagents for SARS-CoV-2 testing.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.